Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate in Newly Diagnosed Multiple Myeloma
NCT00376883Phase 3Completed
- Sponsor
- Nordic Myeloma Study Group
- Start
- Jan 2000
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of pamidronate in multiple myeloma (MM), sponsored by Nordic Myeloma Study Group. Started Jan 2000; status: completed.
02
Drugs
pamidronate
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00376883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376883.